8,084views
of complete
of complete
2024
2023
2022
2021
glycoprotein IIb/IIa inhibitors for p. 442
glycoprotein IIb/IIa inhibitors p. 442
hyperlipidemia p. 307
atherosclerosis and p. 305
atypical antipsychotics p. 591
glomerular filtration barrier and p. 599
immunosuppressants p. 118
nephrotic syndrome p. 613
thiazides p. 627
hyperlipidemia signs p. 307
glycoprotein IIb/IIa inhibitors as cause p. 442
hyperlipidemia and p. 307
Hyperlipidemia is a condition where you have high levels of lipids in your blood, specifically above 200 mg/dL of triglycerides and above 190 mg/dL of cholesterol. Among the causes of hyperlipidemia are genetic predisposition, high-fat diet, and sedentary lifestyle. There are also secondary causes like diabetes mellitus, metabolic disorders such as hypothyroidism. Hyperlipidemia can lead to cardiovascular and cerebrovascular diseases such as myocardial infarction and stroke.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.